
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBAFounder, Bio Founders
Physician and author focused on digital transformation in pharmaceuticals.
Advises pharmaceutical groups on digital health strategy.
Emmanuel Fombu is a physician and author working at the intersection of medicine, technology and business. After clinical training and roles in the pharmaceutical industry, including at Johnson and Johnson, he became an author, speaker and entrepreneur focused on digital health, later founding Bio Founders.
How Emmanuel Fombu got here, step by step.
2000s
Fombu completed clinical training, including at Emory Crawford Long Hospital, before moving into industry.
2000s to 2010s
He held roles across drug development, medical affairs and strategy within the pharmaceutical industry.
2010s
Fombu led global strategy and digital innovation work at Johnson and Johnson, focusing on emerging health technology.
2018
He wrote a book examining how people and machines can work together to improve healthcare outcomes.
2010s to 2020s
Fombu became a frequent international keynote speaker on digital health, artificial intelligence and medical innovation.
2020s
He founded Bio Founders to support entrepreneurs across the biotechnology and health technology sectors.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Dr. Dereck Mush, MD, MBAKeep exploring